Skip To Main Content
About
Our Mission
Portfolio
News
Columns
Contact
Search
Tag: top-line data
Daily IPL344 for up to 3 years seen to slow ALS progression in trial
January 24, 2024
By Lindsey Shapiro, PhD
PrimeC safe, shows trends toward slowing ALS progression: Trial data
December 12, 2023
By Margarida Maia, PhD
Top-line results of PARADIGM trial into PrimeC expected by year’s end
November 8, 2023
By Andrea Lobo, PhD
CHMP confirms its initial position against approving AMX0035 in EU
October 16, 2023
By Patricia Inácio, PhD
PARADIGM trial of PrimeC for ALS now fully enrolled with 69 adults
May 22, 2023
By Andrea Lobo, PhD